References
American Academy of Pediatrics Committee on Infectious Diseases. (2014)Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection. [Versión electrónica].Pediatrics, 134(2):e620-38. Doi: 10.1542/peds.2014-1666.
Brady, M., Byington, C., Davies, H., Edwards, K., Jackson, M., Maldonado, Y.(2014). Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection. [Versión electrónica]. Pediatrics, 134(2), e620-38. Doi: 10.1542/peds.2014-1666.
Carande, E., Pollard, A., Drysdale, S. (2016). Management of respiratory syncytial virus bronchiolitis: 2015 survey of members of the European Society for Paediatric Infectious Diseases . [Versión electrónica]. The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale, 2016, 919139537. Doi: 10.1155/2016/9139537
Diagnóstico y tratamiento de bronquiolitis aguda en niñas/niños y en el primer nivel de atención. Guía de evidencias y recomendaciones: Guía de práctica clínica. México, Cenetec; 2015 (consultada el 31 de octubre de 2019). Disponible en: http://www.cenetec.salud.gob.mx/interior/catalogoMaestroGPC.html
Pamela P., Carneiro M., (2017). Immunology of breast milk.[Versión electrónica]. Rev Assoc Med Bras (1992). 2016 Sep;62(6):584-593. doi: 10.1590/1806-9282.62.06.584.
Hashimoto K, Hosoya M. (2017). Neutralizing epitopes of RSV and palivizumab resistance in Japan . [Versión electrónica]. Fukushima J Med Sci. 2017 Dec 19;63(3):127-134. doi: 10.5387/fms.2017-09. Epub 2017 Sep.
Falsey, A., Koval, C., DeVincenzo J., Walsh, E. (2017). Compassionate use experience with high-titer respiratory syncytical virus (RSV) immunoglobulin in RSV-infected immunocompromised persons . [Versión electrónica].Transplant infectious disease: an official journal of the Transplantation Society, 19(2), 1-8. Doi: 10.1111/tid.12657.
Gamiño-Arroyo, A., Moreno-Espinosa S., Llamosas-Gallardo B, Ortiz-Hernández A, Guerrero M, Galindo-Fraga A., et al. (2017).Epidemiology and clinical characteristics of respiratory syncytial virus infections among children and adults in Mexico . [Versión electrónica]. Influenza and other respiratory viruses, 11(1), 48-56. Doi: 10.1111/irv.12414.
Hui, D., Rossi, G., Johnston, S. (2016). SARS, MERS and other Viral Lung Infections. European Respiratory Society publications. 72, 84-109. Doi: 10.1183/2312508X.erm7216
Jans, J., Wicht, O., Widjaja, L., Ahout, L., de Groot, R., Guichelaar, T., et al. (2017). Characteristics of RSV-Specific Maternal Antibodies in Plasma of Hospitalized, Acute RSV Patients under Three Months of Age. [Versión electrónica].PLoS One,12(1):e0170877.Doi.org/10.1371/journal.pone.0170877
Javelle, E., Colson, P., Parola, P., Raoult, D. (2019). Measles, the need for a paradigm shift . [Versión electrónica]. European journal of epidemiology, 1573-7284. Doi: 10.1007/s10654-019-00569-4.
Jounai, N., Yoshioka, M., Tozuka, M., Inoue, K., Oka, T., Miyaji, K., et al. (2017). Age-Specific Profiles of Antibody Responses against Respiratory Syncytial Virus Infection . [Versión electrónica].EBioMedicine, 16 , 124–135. Doi:10.1016/j.ebiom.2017.01.014.
Lee, N., Qureshi, S. (2013). Other Viral Pneumonias Coronavirus, Respiratory Syncytial Virus, Adenovirus, Hantavirus. [Versión electrónica]. Critical care clinics, 29(4), 1045-1068. Doi: 10.1016/j.ccc.2013.07.003
Liu, W., Chen, D., Tan, W., Xu, D., Qiu, S., Zeng, Z., et al. (2016). Epidemiology and Clinical Presentations of Respiratory Syncytial Virus Subgroups A and B Detected with Multiplex Real Time PCR. [Versión electrónica]. PLoS One, 11(10), e0165108. Doi: 10.1371/journal.pone.0165108.
Lukšić, I., Kearns, P., K., Scott, F., Rudan, I., Campbell, H., Nair, H. (2013).Viral etiology of hospitalized acute lower respiratory infections in children under 5 years of age – a systematic review and meta-analysis. . [Versión electrónica]. Croatian medical journal, 54(2), 122–134. Doi:10.3325/cmj.2013.54.122
Mazur, N., Horsley, N., Englund, J., Nederend, M., Magaret, Kumar A., et al. (2019). Breast Milk Prefusion F Immunoglobulin G as a Correlate of Protection Against Respiratory Syncytial Virus Acute Respiratory Illness . [Versión electrónica]. The journal of infectious diseases, 219(1), 59-67. Doi: 10.1093/infdis/jiy477.
Noor, A., Krilov, L. (2018). Respiratory syncytial virus vaccine: where are we now and what comes next? [Versión electrónica]. Expert opinion on biological therapy,18(12), 1247-1256. Doi: 10.1080/14712598.2018.1544239
Nyiro, J., Sande, C., Mutunga, M., Kiyuka, P., Munywoki, P., Scott, J., et al. (2016). Absence of Association between Cord Specific Antibody Levels and Severe Respiratory Syncytial Virus (RSV) Disease in Early Infants: A Case Control Study from Coastal Kenya. [Versión electrónica].PLoS One, 11(11), e0166706. Doi: 10.1371/journal.pone.0166706.
Patel, K., Kirkpatrick C., Nieforth, K., Chanda, S., Zhang, Q., McClure, M., et al. (2019). Respiratory syncytial virus-A dynamics and the effects of lumicitabine, a nucleoside viral replication inhibitor, in experimentally infected humans. [Versión electrónica]. The journal of antimicrobial chemotherapy, 74(2), 442-452. Doi: 10.1093/jac/dky415.
Palmeira, P., Carneiro-Sampaio, M. (2016). Immunology of breast milk . [Versión electrónica]. Revista da Associação Médica Brasileira, 62(6), 584-593. Doi: 10.1590/1806-9282.62.06.584.
Piedimonte, G. (2015). RSV infections: State of the art.[Versión electrónica]. Cleveland Clinic journal of medicine, 82 (11 Suppl 1). Doi: 10.3949/ccjm.82.s1.03
Robledo-Aceves, M., Moreno-Peregrina, M., Velarde-Rivera, F., Ascencio-Esparza, E., Preciado-Figueroa, F., Caniza, M., et al. (2018).Risk factors for severe bronchiolitis caused by respiratory virus infections among Mexican children in an emergency department.[Versión electrónica]Medicine, 97(9), e0057. Doi: 10.1097/MD.0000000000010057.
Sakaguchi, K., Koyanagi. A., Kamachi, F., Harauma, A., Chiba, A., Hisata, K., et al. (2018). Breastfeeding regulates development of immune system through TGF-β in mice pups. [Versión electrónica]. Pediatrics international: official journal of the Japan Pediatric Society, 60(3):224-231. Doi: 10.1111/ped.13507.
Simões, E., Bont, L., Manzoni, P., Fauroux, B., Paes, B., Figueras-Aloy, J., et. al. (2018). Past, Present and Future Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children . [Versión electrónica]. Infectious diseases and therapy, 7(1), 87–120. Doi: 10.1007/s40121-018-0188-z.
Shay, A., Holman, R., Newman, R., Liu, L., Stout, J., Anderson, L. (1999). Bronchiolitis-associated hospitalizations among US children, 1980-1996. [Versión electrónica]. The Journal of the American Medical Association, 282(15), 1440-6. DOI: 10.1001/jama.282.15.1440.
Shi T., David A McAllister, D., O’Brien, K., Simoes, E., Madhi, S., Gessner, B. (2017). Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. [Versión electrónica]. Lancet, 390 (10098), 946–958.
Vissers, M., Ahout, I.,de Jonge, M., Ferwerda, G. (2016). Mucosal IgG Levels Correlate Better with Respiratory Syncytial Virus Load and Inflammation than Plasma IgG Levels. [Versión electrónica].Clinical and vaccine immunology, 23(3), 243-245. Doi: 10.1128/CVI.00590-15.
Walsh, E., Wang, L., Falsey, A., Qiu, X., Corbett, A., Holden-Wiltse, J., et al. (2018).Virus-Specific Antibody, Viral Load, and Disease Severity in Respiratory Syncytial Virus Infection. [Versión electrónica].The journal of infectious diseases, 218(2), 208-217. Doi: 10.1093/infdis/jiy106.
Xing, Y., Proesmans, M. (2019).New therapies for acute RSV infections: where are we? [Versión electrónica].European journal of pediatrics, 178(2),131-138.